188 related articles for article (PubMed ID: 29152646)
1. Naringin protects myocardial cells from doxorubicin‑induced apoptosis partially by inhibiting the p38MAPK pathway.
Jian CY; Ouyang HB; Xiang XH; Chen JL; Li YX; Zhou X; Wang JY; Yang Y; Zhong EY; Huang WH; Zhang HW
Mol Med Rep; 2017 Dec; 16(6):9457-9463. PubMed ID: 29152646
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of deep sea water against doxorubicin‑induced cardiotoxicity in H9c2 cardiac muscle cells.
Lee DH; Kim S; Nam KS
Int J Oncol; 2014 Dec; 45(6):2569-75. PubMed ID: 25270851
[TBL] [Abstract][Full Text] [Related]
4. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
5. Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway.
Zhang L; Feng M; Wang X; Zhang H; Ding J; Cheng Z; Qian L
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649779
[TBL] [Abstract][Full Text] [Related]
6. Protective Effect of Two Alkaloids from
Zhou W; Ouyang J; Hu N; Li G; Wang H
Molecules; 2021 Mar; 26(7):. PubMed ID: 33808398
[TBL] [Abstract][Full Text] [Related]
7. A herbal formula, SYKT, reverses doxorubicin‑induced myelosuppression and cardiotoxicity by inhibiting ROS‑mediated apoptosis.
Chen T; Shen HM; Deng ZY; Yang ZZ; Zhao RL; Wang L; Feng ZP; Liu C; Li WH; Liu ZJ
Mol Med Rep; 2017 Apr; 15(4):2057-2066. PubMed ID: 28260045
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the leptin-induced activation of the p38 MAPK pathway contributes to the protective effects of naringin against high glucose-induced injury in H9c2 cardiac cells.
Chen J; Mo H; Guo R; You Q; Huang R; Wu K
Int J Mol Med; 2014 Mar; 33(3):605-12. PubMed ID: 24399619
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide attenuates doxorubicin‑induced cardiotoxicity by inhibiting calreticulin expression in H9c2 cells.
Liu MH; Zhang Y; Lin XL; He J; Tan TP; Wu SJ; Yu S; Chen L; Chen YD; Fu HY; Yuan C; Li J
Mol Med Rep; 2015 Oct; 12(4):5197-202. PubMed ID: 26134131
[TBL] [Abstract][Full Text] [Related]
10. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes.
Liu MH; Lin XL; Zhang Y; He J; Tan TP; Wu SJ; Liu J; Tian W; Chen L; Yu S; Li J; Yuan C
Mol Med Rep; 2015 Nov; 12(5):6841-8. PubMed ID: 26299281
[TBL] [Abstract][Full Text] [Related]
12. Lotusine, an alkaloid from Nelumbo nucifera (Gaertn.), attenuates doxorubicin-induced toxicity in embryonically derived H9c2 cells.
Harishkumar R; Selvaraj CI
In Vitro Cell Dev Biol Anim; 2020 May; 56(5):367-377. PubMed ID: 32468412
[TBL] [Abstract][Full Text] [Related]
13. Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
Chen J; Guo R; Yan H; Tian L; You Q; Li S; Huang R; Wu K
Basic Clin Pharmacol Toxicol; 2014 Apr; 114(4):293-304. PubMed ID: 24118820
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of CUEDC2 prevents doxorubicin‑induced cardiotoxicity in H9c2 cells.
Zhang X; Li J; Cheng Y; Yi J; Liu X; Cheng W
Mol Med Rep; 2018 Jul; 18(1):855-863. PubMed ID: 29845245
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide protects H9c2 cardiac cells against doxorubicin-induced cytotoxicity through the PI3K/Akt/FoxO3a pathway.
Liu MH; Zhang Y; He J; Tan TP; Wu SJ; Guo DM; He H; Peng J; Tang ZH; Jiang ZS
Int J Mol Med; 2016 Jun; 37(6):1661-8. PubMed ID: 27081862
[TBL] [Abstract][Full Text] [Related]
16. Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance.
Robinson P; Kasembeli M; Bharadwaj U; Engineer N; Eckols KT; Tweardy DJ
Biomed Res Int; 2016; 2016():1959270. PubMed ID: 26981525
[TBL] [Abstract][Full Text] [Related]
17. Punicalagin protects H9c2 cardiomyocytes from doxorubicin-induced toxicity through activation of Nrf2/HO-1 signaling.
Ye M; Zhang L; Yan Y; Lin H
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015369
[TBL] [Abstract][Full Text] [Related]
18. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
[TBL] [Abstract][Full Text] [Related]
19. p-Coumaric acid mediated protection of H9c2 cells from Doxorubicin-induced cardiotoxicity: Involvement of augmented Nrf2 and autophagy.
Sunitha MC; Dhanyakrishnan R; PrakashKumar B; Nevin KG
Biomed Pharmacother; 2018 Jun; 102():823-832. PubMed ID: 29605770
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress.
Zhao L; Tao X; Qi Y; Xu L; Yin L; Peng J
Redox Biol; 2018 Jun; 16():189-198. PubMed ID: 29524841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
